Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD-Reference-Cited by-同舟云学术

Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD

Published:2023-07-20 Issue:10 Volume:47 Page:986-992
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

De Arka^ORCID,Mehta Manu,Singh Priya,Bhagat Naveen,Mitra Suvradeep,Das Ashim,Duseja Ajay^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://www.nature.com/articles/s41366-023-01346-w.pdf

Reference36 articles.

1. Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh T, et al. Prevalence of non-alcoholic fatty liver disease in india: a systematic review and meta-analysis, J Clin Exp Hepatol. 2021. https://doi.org/10.1016/j.jceh.2021.11.010.

2. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. https://doi.org/10.1002/hep.28431.

3. De A, Duseja A. Natural history of simple steatosis or nonalcoholic fatty liver. J Clin Exp Hepatol. 2020;10:255–62. https://doi.org/10.1016/j.jceh.2019.09.005.

4. Ekstedt M, Nasr P, Kechagias S. Natural history of NAFLD/NASH. Curr Hepatol Rep. 2017;16:391–7. https://doi.org/10.1007/s11901-017-0378-2.

5. Young S, Tariq R, Provenza J, Satapathy SK, Faisal K, Choudhry A, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020;4:953–72. https://doi.org/10.1002/hep4.1519.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease;Journal of Clinical and Experimental Hepatology;2025-01

2. Dysfunctional VLDL metabolism in MASLD;npj Metabolic Health and Disease;2024-07-22

3. Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison;International Journal of Molecular Sciences;2024-07-05

4. Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective;Hepatology International;2024-05-08

5. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians;Journal of Gastroenterology and Hepatology;2024-05-02